Cargando…
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
BACKGROUND: Basal-like breast cancer (BLBC) is one of the most aggressive malignant diseases in women with an increased metastatic behavior and poor prognosis compared to other molecular subtypes of breast cancer. Resistance to chemotherapy is the main cause of treatment failure in BLBC. Therefore,...
Autores principales: | Pantelaiou-Prokaki, Garyfallia, Mieczkowska, Iga, Schmidt, Geske E., Fritzsche, Sonja, Prokakis, Evangelos, Gallwas, Julia, Wegwitz, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753869/ https://www.ncbi.nlm.nih.gov/pubmed/35016723 http://dx.doi.org/10.1186/s13148-022-01228-4 |
Ejemplares similares
-
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments
por: Mieczkowska, Iga K., et al.
Publicado: (2021) -
ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness
por: Werner, Marcel, et al.
Publicado: (2022) -
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer
por: Prokakis, Evangelos, et al.
Publicado: (2023) -
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response
por: Prokakis, Evangelos, et al.
Publicado: (2021) -
CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo
por: Florian, Wegwitz, et al.
Publicado: (2016)